March 19, 2026

Lab Markers May Guide Lupus Biologic Use

Analysis of 31 trials links serologic activity and disease severity to improved response.

Conexiant

March 17, 2026

The Missing Step in Pediatric Lupus Care

Survey data show gaps between rheumatologists’ beliefs and clinical practice in screening and neuropsychological evaluation for childhood-onset systemic lupus erythematosus

Conexiant

March 17, 2026

Can Biomarkers Refine Psych Dx?

Emerging evidence suggests biologic signals may predict treatment response and improve outcomes.

KFF Health News

March 13, 2026

Dry Eye Across Autoimmune Diseases

The nationwide analysis found the highest rates of dry eye disease among patients with Sjögren’s syndrome.

Conexiant

March 05, 2026

Anti-CD146 Linked to Silica in Systemic Sclerosis

Comparative analysis across exposed workers, cancer controls, and healthy donors supports specificity.

Conexiant

January 27, 2026

AI Scribes: Efficiency for Whom?

Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.

Conexiant

April 29, 2024

A Look Ahead at Rheumatology in 2024

A rheumatologist reflected on rheumatology developments in 2023 and looked ahead to the developments and challenges the field may face in 2024.

Conexiant

April 30, 2024

Potential New Lyme Disease Therapy Advances to Human Safety Trials

The novel antibiotic therapy hygromycin A has advanced to human safety trials to determine its potential as a future treatment for Lyme disease.

Conexiant

April 29, 2024

Methotrexate Response in Patients With Juvenile Idiopathic Arthritis

A machine-learning model may help predict how patients with juvenile idiopathic arthritis respond to treatment with methotrexate.

Conexiant

November 18, 2024

Apocrine Gland Changes in Early Hidradenitis Suppurativa

A recent study in the Journal of Investigative Dermatology identified potential early factors in the development of hidradenitis suppurativa, involving apocrine gland damage and keratin release, offering insights into potential biomarkers for disease severity and progression.

Conexiant